Literature DB >> 12149539

"CF asthma": what is it and what do we do about it?

I M Balfour-Lynn1, J S Elborn.   

Abstract

The diagnosis of "CF asthma" is problematic and it is difficult to determine which patients have a combination of CF and asthma and which have asthma like symptoms caused by inflammation of the CF lung. This may not matter, however; the relevance lies in the possible approaches to treatment.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12149539      PMCID： PMC1746393          DOI： 10.1136/thorax.57.8.742

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


  65 in total

1.  Tracheal mucociliary transport in patients with cystic fibrosis and its stimulation by terbutaline.

Authors:  R E Wood; A Wanner; J Hirsch; P M Farrell
Journal:  Am Rev Respir Dis       Date:  1975-06

2.  Bronchial lability in cystic fibrosis.

Authors:  G Day; M B Mearns
Journal:  Arch Dis Child       Date:  1973-05       Impact factor: 3.791

Review 3.  Treatment of severe small airways disease in children with cystic fibrosis: alternatives to corticosteroids.

Authors:  Adam Jaffe; Ian M Balfour-Lynn
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 4.  Children with difficult asthma: a practical approach.

Authors:  D N Payne; I M Balfour-Lynn
Journal:  J Asthma       Date:  2001-05       Impact factor: 2.515

5.  Beclomethasone diproprionate reduced airway inflammation without adrenal suppression in young children with cystic fibrosis: a pilot study.

Authors:  H A Wojtczak; G S Kerby; J S Wagener; S C Copenhaver; R W Gotlin; D W Riches; F J Accurso
Journal:  Pediatr Pulmonol       Date:  2001-10

6.  Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis.

Authors:  S Holt; A Suder; M Weatherall; S Cheng; P Shirtcliffe; R Beasley
Journal:  BMJ       Date:  2001-08-04

7.  Variability of airways hyper-reactivity and allergy in cystic fibrosis.

Authors:  F J Holzer; A Olinsky; P D Phelan
Journal:  Arch Dis Child       Date:  1981-06       Impact factor: 3.791

8.  Within-subject variability and per cent change for significance of spirometry in normal subjects and in patients with cystic fibrosis.

Authors:  B G Nickerson; R J Lemen; C B Gerdes; M J Wegmann; G Robertson
Journal:  Am Rev Respir Dis       Date:  1980-12

9.  Intravenous aminophylline in patients with cystic fibrosis. Pharmacokinetics and effect on pulmonary function.

Authors:  G L Larsen; R J Barron; R A Landay; E K Cotton; M A Gonzalez; J G Brooks
Journal:  Am J Dis Child       Date:  1980-12

10.  Bronchodilators increase airway instability in cystic fibrosis.

Authors:  M S Zach; B Oberwaldner; G Forche; G Polgar
Journal:  Am Rev Respir Dis       Date:  1985-04
View more
  19 in total

Review 1.  Asthma in cystic fibrosis.

Authors:  Ian M Balfour-Lynn
Journal:  J R Soc Med       Date:  2003       Impact factor: 5.344

2.  Early childhood wheezing is associated with lower lung function in cystic fibrosis.

Authors:  Clement L Ren; Michael W Konstan; Margaret Rosenfeld; David J Pasta; Stefanie J Millar; Wayne J Morgan
Journal:  Pediatr Pulmonol       Date:  2013-10-01

Review 3.  Asthma in Cystic Fibrosis: Definitions and Implications of This Overlap Syndrome.

Authors:  Chad R Marion; Manuel Izquierdo; Holly C Hanes; Christopher Barrios
Journal:  Curr Allergy Asthma Rep       Date:  2021-02-09       Impact factor: 4.806

4.  Cystic Fibrosis Transmembrane Conductance Regulator in Sarcoplasmic Reticulum of Airway Smooth Muscle. Implications for Airway Contractility.

Authors:  Daniel P Cook; Michael V Rector; Drake C Bouzek; Andrew S Michalski; Nicholas D Gansemer; Leah R Reznikov; Xiaopeng Li; Mallory R Stroik; Lynda S Ostedgaard; Mahmoud H Abou Alaiwa; Michael A Thompson; Y S Prakash; Ramaswamy Krishnan; David K Meyerholz; Chun Y Seow; David A Stoltz
Journal:  Am J Respir Crit Care Med       Date:  2016-02-15       Impact factor: 21.405

Review 5.  Treatment of severe small airways disease in children with cystic fibrosis: alternatives to corticosteroids.

Authors:  Adam Jaffe; Ian M Balfour-Lynn
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

6.  Acute administration of ivacaftor to people with cystic fibrosis and a G551D-CFTR mutation reveals smooth muscle abnormalities.

Authors:  Ryan J Adam; Katherine B Hisert; Jonathan D Dodd; Brenda Grogan; Janice L Launspach; Janel K Barnes; Charles G Gallagher; Jered P Sieren; Thomas J Gross; Anthony J Fischer; Joseph E Cavanaugh; Eric A Hoffman; Pradeep K Singh; Michael J Welsh; Edward F McKone; David A Stoltz
Journal:  JCI Insight       Date:  2016-04-07

7.  Asthma in children with sickle cell disease and its association with acute chest syndrome.

Authors:  J M Knight-Madden; T S Forrester; N A Lewis; A Greenough
Journal:  Thorax       Date:  2005-03       Impact factor: 9.139

8.  Intravenous immunoglobulin for cystic fibrosis lung disease: a case series of 16 children.

Authors:  I M Balfour-Lynn; U Mohan; A Bush; M Rosenthal
Journal:  Arch Dis Child       Date:  2004-04       Impact factor: 3.791

Review 9.  Association of CFTR gene mutation with bronchial asthma.

Authors:  Nutan Maurya; Shally Awasthi; Pratibha Dixit
Journal:  Indian J Med Res       Date:  2012-04       Impact factor: 2.375

Review 10.  Cystic Fibrosis Human Organs-on-a-Chip.

Authors:  Herbert Luke Ogden; Hoyeol Kim; Kathryn A Wikenheiser-Brokamp; Anjaparavanda P Naren; Kyu Shik Mun
Journal:  Micromachines (Basel)       Date:  2021-06-25       Impact factor: 2.891
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.